Souhaitez-vous accéder aux communiqués récents ?

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters combination evaluation with trabectedin (Yondelis®) with...

The technology, which will be acquired for US$5 million, allows for the separation of X and Y chromosome-bearing sperm cells MicroSort offers several advantages for those seeking reproductive...

  Louvain-La-Neuve, Belgium, 21 January 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and Wallonie Entreprendre International (WE...

New York, United States, Jan. 20, 2025 (GLOBE NEWSWIRE) -- A biopsy is a procedure where a small amount of tissue is extracted for examination under a microscope. In the case of a core biopsy,...

Canada’s national nuclear laboratories announces new projects with leading Canadian biopharmaceutical companies through collaborative research program CHALK RIVER, Ontario, Jan. 20, 2025 (GLOBE...

New York, United States, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Gene therapy prevents the progression of an illness by altering the expression of mutated genes or the biological characteristics of living...

Deriv was named the “Most Innovative Broker - MEA 2025” at this year’s Dubai iFXEXPO, highlighting the company’s commitment to groundbreaking innovation.

Rockville, MD, Jan. 20, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global RNA transcriptome profiling test market is estimated to...

Segra International is pleased to announce a strategic partnership with GreenBe Pharma, a premier European medicinal cannabis producer.

WASHINGTON, Jan. 18, 2025 (GLOBE NEWSWIRE) -- In a historic celebration of leadership and technological innovation, Brock Pierce, DNA Holdings, and Ambassador Paolo Zampolli are proud to host the...